Sumitomo Mitsui Trust Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$117M Sell
2025
Q1
$86.4M Sell
2024
Q4
$108M Sell
2024
Q3
$139M Sell
2024
Q2
$170M Sell
2024
Q1
$223M Sell
2023
Q4
$211M Sell
2023
Q3
$157M Sell
2023
Q2
$198M Sell
2023
Q1
$180M Sell
2022
Q4
$163M Sell
2022
Q3
$279M Sell
2022
Q2
$279M Sell
2022
Q1
$290M Buy